Moderna Named a Top Employer by Science for Twelfth Consecutive Year

CAMBRIDGE, MA / ACCESS Newswire / October 23, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top ...

MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer

Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this ...
Kauppalehti

Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)

Sefaxersen achieved a statistically significant 43.1% reduction in proteinuria, a key indicator of kidney damage, relative to placebo at 37 weeks with consistent treatment effects across all ...

Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial

Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in a trial.